Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya (Q36509801)

14 August 2017

Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya (English)

1 reference

14 August 2017

0 references

1 reference

1 reference

5

Connie Celum

1 reference

14 August 2017

6

Carey Farquhar

1 reference

14 August 2017

8

Jared M Baeten

1 reference

14 August 2017

2

Nelly Mugo

1 reference

14 August 2017

3

Kenneth Ngure

1 reference

14 August 2017

1

Elizabeth Irungu

1 reference

14 August 2017

Robert Njuguna

4

1 reference

PMCID

3537443

14 August 2017

Shireesha Dhanireddy

series ordinal

7

1 reference

PMCID

3537443

14 August 2017

language of work or name

English

0 references

publication date

21 November 2012

1 reference

Journal of Infectious Diseases

14 August 2017

1 reference

14 August 2017

207

1 reference

14 August 2017

3

1 reference

14 August 2017

402-410

1 reference

Meta-analysis: the impact of nutritional status on the immune response to hepatitis B virus vaccine in chronic kidney disease

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Factors associated with seroconversion after standard dose hepatitis B vaccination and high-dose revaccination among HIV-infected patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Efficacy of double-dose hepatitis B rescue vaccination in HIV-infected patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Nutritional formula improved immune profiles of seniors living in nursing homes.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Evaluation of the response to vaccination against poliomyelitis and measles in malnourished children in Morocco

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Co-administration of l-cystine and l-theanine enhances efficacy of influenza vaccination in elderly persons: nutritional status-dependent immunogenicity

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

HIV, hepatitis B and hepatitis C coinfection in Kenya

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537443

Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons

21 September 2018

1 reference

12 December 2020

Repeat hepatitis B vaccination may lead to seroprotection in HIV-infected patients who do not respond to an initial series

1 reference

12 December 2020

Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load

1 reference

12 December 2020

Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose

1 reference

12 December 2020

High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects

1 reference

12 December 2020

Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients

1 reference

12 December 2020

Identifiers

DOI

10.1093/INFDIS/JIS695

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

PMCID

3537443